Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver

Biochemical Pharmacology

Volumn 55, Issue 11, 1998, Pages 1915-1920

  Adams, Melissa D ^a   Raman, Priya ^a   Judd, Robert L ^a  

^a Division of Molecular Pharmacology   (United States)

Author keywords

Englitazone; Glucuneogenesis; Glyburide; Glycolys is; Sulfonylurea; Thiazolidinedione

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CP 68; ENGLITAZONE; GLIBENCLAMIDE; GLUCOSE; INSULIN; SULFONYLUREA; TROGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ENZYME ASSAY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOLYSIS; INSULIN SENSITIVITY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZOPYRANS; DIHYDROXYACETONE; FRUCTOSE; GLUCONEOGENESIS; GLUCOSE; GLYBURIDE; GLYCEROL; GLYCOLYSIS; HYPOGLYCEMIC AGENTS; LACTIC ACID; LIVER; MALE; PERFUSION; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0032101531     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00052-5     Document Type: Article

References (31)

1. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:1992;318-368.
2. Patel T.B. Effects of tolbutamide on gluconeogenesis and glycolysis in isolated perfused rat liver. Am J Physiol. 250:1986;E82-E86.
3. Jacobs D.B., Hayes G.R., Lockwood D.H. In vitro effects of sulfonylureas on glucose transport and translocation of glucose transporters in adipocytes from streptozoticin-induced diabetic rats. Diabetes. 38:1989;205-211.
4. Gerich J.E. Oral hypoglycemic agents. N Engl J Med. 321:1989;1231-1245.
5. Melander A., Bitzen P., Faber O., Groop L. Sulfonylurea antidiabetic drugs An update of their clinical pharmacology and rational therapeutic use . Drugs. 37:1989;58-72.
6. Hofmann C.A., Colca J.R. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care. 15:1992;1075-1078.
7. Chang A.Y., Wyse B.M., Gilchrist B.J., Peterson T., Diani A.R. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Diabetes. 32:1983;1830-1838.
8. Fujiwara T., Yoshioka S., Yoshioka T., Ushiyama I., Horikoshi H. Characterization of new oral antidiabetic agent CS-045 Studies in KK and ob/ob mice and Zucker fatty rats . Diabetes. 37:1988;1549-1558.
9. Stevenson R.W., Hutson N.J., Krupp M.N., Volkmann R.A., Holland G.F., Eggler J.F., Clark D.A., McPherson R.K., Hall K.L., Danbury B.H., Gibbs E.M., Kreutter D.K. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice. Diabetes. 39:1990;1218-1227.
10. Kruetter D.K., Andrews K.M., Gibbs E.M., Hutson N.J., Stevenson R.W. Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes. Diabetes. 39:1990;1414-1419.
11. Gibbs E.M., Genereux P.E., Kreutter D.K. Antidiabetic agent CP 68,722 increases levels of glucose transport and glucose transporter protein in 3T3-L1 adipocytes. Diabetologia. 32:1989;491A.
12. Stevenson R.W., McPherson R.K., Genereux P.E., Danbury B.H., Kreutter D.K. Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia. Metabolism. 40:1991;1268-1274.
13. Blackmore P.F., McPherson R.K., Stevenson R.W. Actions of the novel antidiabetic agent englitazone in rat hepatocytes. Metabolism. 42:1993;1583-1587.
14. Bowen L., Stein P.P., Stevenson R.W., Schulman G.I. The effect of CP 68,722, a thiazolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats. Metabolism. 40:1991;1538-1544.
15. McPherson R.K., Gibbs E.M., Treadway J.L., Stevenson R.W. Englitazone effects on signal transduction and metabolic response to insulin and glucagon in isolated rat hepatocytes. Diabetes. 42:1993;36A.
16. Scholz R., Hansen W., Thurman R.G. Interactions of mixed-function oxidation with biosynthetic processes. Eur J Biochem. 38:1973;64-72.
17. Bergmeyer H.U., Bernt E., Schmidt F., Stork H. D-Glucose. Bergmeyer H.U. Methods of Enzymatic Analysis. Vol. 3:1974;1196-1198 Academic Press, New York.
18. Czok R., Lamprecht W. Pyruvate, phosphoenolpyruvate and D-glycerate-2-phosphate. Bergmeyer H.U. Methods of Enzymatic Analysis. Vol. 3:1974;1446-1451 Academic Press, New York.
19. Gutmann I., Wahlefeld A.W. L-(+)Lactate determination with lactate dehydrogenase and NAD. Bergmeyer H.U. Methods of Enzymatic Analysis. Vol. 3:1974;1464-1468 Academic Press, New York.
20. Saltiel A.R., Olefsky J.M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 45:1996;1661-1669.
21. Ciaraldi T.P., Gilmore A., Olefsky J.M., Goldber M., Heidenreich K.A. In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism. 39:1990;1056-1062.
22. Spencer C.M., Markhan A. Troglitazone. Drugs. 54:1997;89-101.
23. Chen H., Hamel F.G., Siford G., Duckworth W.C. Alteration of rat hepatic insulin metabolism by glyburide and glipizide. J Pharmacol Exp Ther. 264:1993;1293-1298.
24. Fulgencio J., Kohl C., Girard J., Pegorier J. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated rat hepatocytes from starved rats. Diabetes. 45:1996;1556-1562.
25. Foster S.E., Raman P., Judd R.L. Effect of troglitazone on hepatic fructose-2,6-bisphosphate concentration and glucose metabolism. Diabetes. 46:1997;225A.
26. Marano K., Inoue Y., Emot M., Kaku K., Kaneko T. CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes. Eur J Pharmacol. 254:1994;257-262.
27. Cabello M.A., Monge L., Ortega J.L., Samper B., Feliu J.E. Effect of glipizide on hepatic fructose 2,6-bisphosphate concentrations and glucose metabolism. Metabolism. 36:1987;738-742.
28. Hue L., Bartron R. Role of fructose-2,6-bisphosphate in the control by glucagon of gluconeogenesis from various precursors in isolated rat hepatocytes. Biochem J. 218:1984;165-170.
29. Judd R.L., Kunjathoor V.V., Pillai U.A., Ferguson P.W., Medon P.J. Effect of tolbutamide and glyburide on pyruvate kinase flux in isolated rat hepatocytes. Life Sci. 50:1992;L203-PL208.
30. Hofmann C., Lorenz K., Williams D., Palazuk B.J., Colca J.R. Insulin sensitization in diabetic rat liver by an antihyperglycemic agent. Metabolism. 44:1995;384-389.
31. Sarges R., Hank R.F., Blake J.F., Bordner J., Bussolotti D.L., Hargrove D.M., Treadway J.L., Gibbs E.M. Glucose transport-enhancing and hypoglycemic activity of 2-methyl-2-phenoxy-3-phenylpropanoic acids. J Med Chem. 39:1996;4783-4803.